CoreAge Rx vs RxSpan MD
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and RxSpan MD head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 72 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make RxSpan MD a bad call — it's best for readers who want to check who is prescribing and who is compounding before they buy, and who will change the pre-selected plan back to monthly unless they actually mean to pay a year up front. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | RxSpan MD |
|---|---|---|
| Brief Score | 94/100 (A) | 72/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $249/mo month-to-month, compounded — the funnel pre-selects a 3-month prepay at $657 up front, and its cheapest rung is $2,327 for a year in one charge |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $329/mo month-to-month, compounded — 3 months bills $927 up front, 12 months $3,228 |
| Coverage | US only; restrictions by state, confirmed at intake | All 50 states claimed — asynchronous review is not available in all of them |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
RxSpan MD: Month-to-month injections cost $249 for semaglutide and $329 for tirzepatide. The $194 and $269 monthly equivalents require upfront payments of $2,327 and $3,228; lower unpublished catalog figures are not purchasable storefront offers.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.